Dr Philip A Marshall

Non-Executive Director

BSc (Hons), PhD, FRACI, CChem

Philip has over 40 years’ practical experience in all aspects of commercial drug development from discovery, formulation, scale-up, manufacture, pre-clinical and clinical studies, quality/regulatory compliance, and intellectual property. It started in his PhD through to his various pharma roles including Mayne, Pfizer, Numico and Sigma. He has served as an independent Expert Witness on many pharmaceutical patent matters in international jurisdictions, and as an authorised auditor (retired) he conducted GMP audits worldwide on behalf of the Australian government.

Philip is passionate about the science of drug development. His success through his independent consultancy business is based on assisting companies developing medicines in all phases of development to ensure they are formulated and manufactured to deliver their maximum therapeutic efficiency, safety, and regulatory compliance while providing a commercial advantage.